{
    "2019-01-18": [
        [
            {
                "time": "2018-01-18",
                "original_text": "新基建成北上资金扫货新宠",
                "features": {
                    "keywords": [
                        "新基建",
                        "北上资金",
                        "扫货"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基建"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "下周两市620亿市值限售股解禁，环比增加102.07% 解禁",
                "features": {
                    "keywords": [
                        "限售股",
                        "解禁",
                        "市值"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "170亿！北上资金单周净买入额再创年内新高，积极布局两大板块",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净买入",
                        "年内新高",
                        "布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "医药生物行业:国家集采文件落地,顶层制度建设出台",
                "features": {
                    "keywords": [
                        "医药生物",
                        "国家集采",
                        "顶层制度"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "医疗保健：关注各部委2019年顶层设计工作重点 强烈推荐创新服务商+注射剂国际化",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "顶层设计",
                        "创新服务商",
                        "注射剂国际化"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "抗癌神药“PD-1”的战争",
                "features": {
                    "keywords": [
                        "抗癌神药",
                        "PD-1"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "医药生物一致性评价品种带量集采：长期方向确定，逐步推进形成稳定预期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一致性评价",
                        "带量集采"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "医药板块全线走强，华海药业冲击涨停",
                "features": {
                    "keywords": [
                        "医药板块",
                        "华海药业",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "花旗：料药股短期仍波动 集采城市报销制利好中生制药(01177.HK)",
                "features": {
                    "keywords": [
                        "花旗",
                        "药股",
                        "波动",
                        "集采",
                        "中生制药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "辽宁32个抗癌药调整价格，降幅较大的近30％！",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "价格调整",
                        "降幅"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}